Cambridge Antibody Technology

Summary

Cambridge Antibody Technology is a business^[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (24 views/month).^[2]

Key Facts

• Cambridge Antibody Technology's instance of is recorded as business^[3].
• Cambridge Antibody Technology's instance of is recorded as public company^[4].
• Cambridge Antibody Technology's founder is recorded as David Chiswell^[5].
• Cambridge Antibody Technology's founder is recorded as John McCafferty^[6].
• Cambridge Antibody Technology's logo image is recorded as Black with strap v2.png^[7].
• Cambridge Antibody Technology's followed by is recorded as AstraZeneca (United States)^[8].
• Cambridge Antibody Technology's stock exchange is recorded as Nasdaq^[9].
• +1989-00-00T00:00:00Z marks the founding of Cambridge Antibody Technology^[10].
• Cambridge Antibody Technology's Freebase ID is recorded as /m/06wbqqr^[11].
• Cambridge Antibody Technology's parent organization or unit is recorded as AstraZeneca^[12].
• Cambridge Antibody Technology's product or material produced is recorded as adalimumab^[13].
• Cambridge Antibody Technology's Quora topic ID is recorded as Cambridge-Antibody-Technology^[14].

Body

Founding

Founders include David Chiswell^[5] and John McCafferty^[6]. +1989-00-00T00:00:00Z marks the founding of Cambridge Antibody Technology^[10].

Identity

Cambridge Antibody Technology's followed by is recorded as AstraZeneca (United States)^[8].

Operations

Cambridge Antibody Technology's parent organization or unit is recorded as AstraZeneca^[12].

Ownership

Cambridge Antibody Technology's stock exchange is recorded as Nasdaq^[9]. Its product or material produced is recorded as adalimumab^[13].

Why It Matters

Cambridge Antibody Technology ranks in the top 4% of business entities by monthly Wikipedia readership (24 views/month).^[2]